Contact Us

SEC Filings

Investor Contacts

Jeff Macdonald
Executive Director,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717

SEC Filings

Filing date	Form	Description	Filing Group	View
Nov 23, 2009	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001193125-09-240424.pdf 0001193125-09-240424.rtf 0001193125-09-240424.xls
Nov 23, 2009	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	Registration Statements	View HTML 0001193125-09-240429.pdf 0001193125-09-240429.rtf 0001193125-09-240429.xls
Nov 19, 2009	RW	Withdrawal of registration statement filed under the Securities Act	Other	View HTML 0001193125-09-238545.pdf 0001193125-09-238545.rtf 0001193125-09-238545.xls
Nov 19, 2009	RW	Withdrawal of registration statement filed under the Securities Act	Other	View HTML 0001193125-09-238549.pdf 0001193125-09-238549.rtf 0001193125-09-238549.xls
Nov 17, 2009	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001232524-09-000022.pdf 0001232524-09-000022.rtf
Nov 13, 2009	EFFECT	EFFECT	Other	View HTML 9999999995-09-003183.pdf 9999999995-09-003183.rtf
Nov 13, 2009	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001232524-09-000021.pdf 0001232524-09-000021.rtf
Nov 10, 2009	S-1/A	Amended Registration statement for face-amount certificate companies	Registration Statements	View HTML 0001193125-09-230879.pdf 0001193125-09-230879.rtf 0001193125-09-230879.xls
Nov 10, 2009	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001193125-09-230637.pdf 0001193125-09-230637.rtf 0001193125-09-230637.xls
Nov 10, 2009	ARS	An annual report to security holders	Annual Filings	View HTML

Data provided by Kaleidoscope.